Jeffrey Zekauskas
JP Morgan | Basic Materials
Jeffrey Zekauskas is an analyst from JP Morgan specializing in the Basic Materials sector. Ranked #1329 out of 4363 analysts, they have issued 47 stock ratings with a success rate of 97.53% and an average return of 6.92%.
Jeffrey Zekauskas has a well-established track record, with 47 ratings issued in the Basic Materials sector. They have consistently delivered a success rate of 97.53% and an average return of 6.92%, underscoring their expertise and ability to identify winning opportunities for investors.
Recent Ratings Analysis
PPG
BuyOct 16, 2025
Target
$112.00
Current
$101.01
Performance
0.00%
Jeffrey Zekauskas rated PPG as Overweight on Oct 16, 2025, setting a price target of 112. Shares have remained stable near 101.01, leaving the 112 target still in play.
TROX
HoldOct 03, 2025
Target
$0.00
Current
$3.68
Performance
-10.02%
On Oct 03, 2025, TROX was given a Neutral rating by Jeffrey Zekauskas, with a target price of null. The rating provided protection from downside risk as the stock fell to 3.68.
CTVA
BuyOct 02, 2025
Target
$70.00
Current
$61.00
Performance
-3.92%
CTVA received a Overweight rating from Jeffrey Zekauskas on Oct 02, 2025, aiming for 70. Price action was muted, as shares hovered around 61 despite the bullish outlook.
WLK
HoldSep 25, 2025
Target
$78.00
Current
$76.05
Performance
0.07%
On Sep 25, 2025, Jeffrey Zekauskas published a Neutral outlook on WLK, with a target of 78. Sideways action left the Hold view intact, with no major move since 76.05.
AMCR
BuySep 19, 2025
Target
$10.00
Current
$8.14
Performance
-1.45%
Jeffrey Zekauskas on Sep 19, 2025 assigned AMCR a Overweight rating, with a price target of 10. The recommendation remains pending validation as shares consolidate around 8.14.
SEE
BuySep 09, 2025
Target
$36.00
Current
$34.15
Performance
2.37%
On Sep 09, 2025, Jeffrey Zekauskas reaffirmed SEE with a Overweight rating, targeting 36. Market indecision has kept the 36 target in a holding pattern.
ALB
HoldAug 18, 2025
Target
$80.00
Current
$95.29
Performance
14.68%
ALB was rated Neutral by Jeffrey Zekauskas on Aug 18, 2025, with a price objective of 80. Despite caution, upside momentum rewarded risk-takers with gains to 95.29.
CE
HoldAug 14, 2025
Target
$40.00
Current
$39.98
Performance
-6.19%
On Aug 14, 2025, Jeffrey Zekauskas initiated coverage on CE with a Neutral rating and target of 40. The rating matched the stock’s inability to hold above 39.98.
CMP
SellAug 13, 2025
Target
$18.00
Current
$18.30
Performance
-4.19%
Jeffrey Zekauskas issued a Underweight recommendation for CMP on Aug 13, 2025, price target set at 18. Investors remain in wait-and-see mode as shares stayed flat.
OEC
SellAug 11, 2025
Target
$9.00
Current
$6.16
Performance
-36.95%
On Aug 11, 2025, OEC was evaluated by Jeffrey Zekauskas, who gave a Underweight rating and target of 9. The recommendation was proven wrong by upward action toward 9.
GNRC
BuyAug 11, 2025
Target
$68.00
Current
$192.64
Performance
-1.97%
Jeffrey Zekauskas rated GNRC as Overweight on Aug 11, 2025, setting a price target of 68. Shares have remained stable near 192.64, leaving the 68 target still in play.
LIN
BuyAug 04, 2025
Target
$475.00
Current
$444.24
Performance
-4.96%
On Aug 04, 2025, LIN was given a Overweight rating by Jeffrey Zekauskas, with a target price of 475. The stock traded sideways with a -4.96% move, keeping the bullish thesis unresolved.
LYB
HoldAug 04, 2025
Target
$52.00
Current
$45.86
Performance
-9.90%
LYB received a Neutral rating from Jeffrey Zekauskas on Aug 04, 2025, aiming for 52. The Hold stance proved prudent, with the market softening by 9.90%.
CF
HoldJul 29, 2025
Target
$92.00
Current
$83.02
Performance
-12.53%
On Jul 29, 2025, Jeffrey Zekauskas published a Neutral outlook on CF, with a target of 92. Weakness in the stock, now at 83.02, supported the conservative rating.
CCK
BuyJul 23, 2025
Target
$112.00
Current
$92.34
Performance
-12.34%
Jeffrey Zekauskas on Jul 23, 2025 assigned CCK a Overweight rating, with a price target of 112. The call has struggled to gain traction, with shares losing 12.34%.
AVY
HoldJul 23, 2025
Target
$182.00
Current
$159.34
Performance
-11.31%
On Jul 23, 2025, Jeffrey Zekauskas reaffirmed AVY with a Neutral rating, targeting 182. The Hold stance reflected market caution that was later justified.
SHW
BuyJul 23, 2025
Target
$378.00
Current
$331.46
Performance
-3.35%
SHW was rated Overweight by Jeffrey Zekauskas on Jul 23, 2025, with a price objective of 378. The stock is in a wait-and-see zone, leaving the Buy case open-ended.
FUL
SellJun 27, 2025
Target
$54.00
Current
$58.68
Performance
-4.94%
On Jun 27, 2025, Jeffrey Zekauskas initiated coverage on FUL with a Underweight rating and target of 54. Sideways trading kept the bearish case unconfirmed with the stock at 58.68.
DOW
HoldApr 04, 2025
Target
$31.00
Current
$21.90
Performance
-22.34%
Jeffrey Zekauskas issued a Neutral recommendation for DOW on Apr 04, 2025, price target set at 31. Market action validated the conservative Hold outlook with shares at 21.9.
ASH
BuyMar 26, 2025
Target
$71.00
Current
$48.94
Performance
-18.05%
On Mar 26, 2025, ASH was evaluated by Jeffrey Zekauskas, who gave a Overweight rating and target of 71. Investors saw limited payoff as shares fell short of the 71 target.
OLN
HoldFeb 27, 2025
Target
$28.00
Current
$23.92
Performance
-4.55%
Jeffrey Zekauskas rated OLN as Neutral on Feb 27, 2025, setting a price target of 28. The Hold stance appears justified, as shares hovered around 23.92 with a -4.55% move.
CBT
SellFeb 21, 2025
Target
$85.00
Current
$69.12
Performance
-18.17%
On Feb 21, 2025, CBT was given a Underweight rating by Jeffrey Zekauskas, with a target price of 85. The bearish stance was challenged as the stock rebounded from 69.12.
IFF
BuyFeb 20, 2025
Target
$104.00
Current
$62.60
Performance
-21.89%
IFF received a Overweight rating from Jeffrey Zekauskas on Feb 20, 2025, aiming for 104. The rating hasn’t played out as hoped, with the stock trading 21.89% below expectations.
HUN
BuyFeb 19, 2025
Target
$22.00
Current
$8.40
Performance
-53.44%
On Feb 19, 2025, Jeffrey Zekauskas published a Overweight outlook on HUN, with a target of 22. Market action contradicted the Buy thesis, as shares slipped to 8.4.
VVV
HoldFeb 13, 2025
Target
$38.00
Current
$34.60
Performance
-13.72%
Jeffrey Zekauskas on Feb 13, 2025 assigned VVV a Neutral rating, with a price target of 38. The call successfully avoided chasing as shares lost 13.72%.
APD
HoldFeb 07, 2025
Target
$320.00
Current
$253.18
Performance
-18.44%
On Feb 07, 2025, Jeffrey Zekauskas reaffirmed APD with a Neutral rating, targeting 320. The Hold stance reflected market caution that was later justified.
SLGN
HoldJan 30, 2025
Target
$57.00
Current
$43.51
Performance
-22.51%
SLGN was rated Neutral by Jeffrey Zekauskas on Jan 30, 2025, with a price objective of 57. Investors who stayed cautious avoided some of the 22.51% decline.
NTR
HoldJan 13, 2025
Target
$50.00
Current
$56.42
Performance
10.20%
On Jan 13, 2025, Jeffrey Zekauskas initiated coverage on NTR with a Neutral rating and target of 50. The Hold stance underestimated the stock’s strength as it gained 10.20%.
RPM
HoldJan 08, 2025
Target
$124.00
Current
$112.74
Performance
-8.02%
Jeffrey Zekauskas issued a Neutral recommendation for RPM on Jan 08, 2025, price target set at 124. Market action validated the conservative Hold outlook with shares at 112.74.
BERY
BuyNov 25, 2024
Target
$76.00
Current
$67.58
Performance
-5.55%
On Nov 25, 2024, BERY was evaluated by Jeffrey Zekauskas, who gave a Overweight rating and target of 76. Investors saw limited payoff as shares fell short of the 76 target.
ECL
HoldJul 31, 2024
Target
$228.00
Current
$270.62
Performance
17.31%
Jeffrey Zekauskas rated ECL as Neutral on Jul 31, 2024, setting a price target of 228. Despite the Hold call, shares climbed 17.31% to 270.62, revealing unexpected momentum.
FMC
HoldMay 13, 2024
Target
$50.00
Current
$29.98
Performance
-55.06%
On May 13, 2024, FMC was given a Neutral rating by Jeffrey Zekauskas, with a target price of 50. The rating provided protection from downside risk as the stock fell to 29.98.
AXTA
BuyMay 02, 2024
Target
$40.00
Current
$27.75
Performance
-20.33%
AXTA received a Overweight rating from Jeffrey Zekauskas on May 02, 2024, aiming for 40. The rating hasn’t played out as hoped, with the stock trading 20.33% below expectations.
BALL
HoldMay 01, 2024
Target
$70.00
Current
$48.06
Performance
-29.61%
On May 01, 2024, Jeffrey Zekauskas published a Neutral outlook on BALL, with a target of 70. Weakness in the stock, now at 48.06, supported the conservative rating.